J Korean Dent Soc Anesthesiol.
2013 Dec;13(4):161-166. 10.17245/jkdsa.2013.13.4.161.
Dexmedetomidine: Clinical Use
- Affiliations
-
- 1Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Korea. anekch@pusan.ac.kr
- KMID: 2345007
- DOI: http://doi.org/10.17245/jkdsa.2013.13.4.161
Abstract
- Dexmedetomidine is a potent alpha-2-adrenergic agonist, more selective than clonidine, with widespread actions on the mammalian brain. A large body of recent work supports its analgesia and sympatholytic properties. Dexmedetomidine is a useful medication with many clinical applications. The medication has shown efficacy in decreasing the need for opioids, benzodiazepines, propofol, and other sedative medications. Dexmedetomidine has been used effectively for sedation during invasive procedures and in the ICU. Short-term sedation has been shown to be safe in studies, although hypotension and bradycardia are the most significant side effects. Dexmedetomidine is emerging as an effective therapeutic agent in the management of a wide range of clinical conditions with an efficacious, safe profile.
Keyword
MeSH Terms
Cited by 2 articles
-
The alternative of oral sedation for pediatric dental care
Jongbin Kim, Seungoh Kim, Deok-Won Lee, Dae-Seung Ryu
J Dent Anesth Pain Med. 2015;15(1):1-4. doi: 10.17245/jdapm.2015.15.1.1.Anesthetic management for simultaneous drug-induced sleep endoscopy and maxillomandibular advancement in a patient with obstructive sleep apnea
Tae Seong Kuk, Eunsun So, Myong-Hwan Karm, Jimin Kim, Seong In Chi, Hyun Jeong Kim, Kwang-Suk Seo, Sung Woon On, Jin-Young Choi
J Dent Anesth Pain Med. 2017;17(1):71-76. doi: 10.17245/jdapm.2017.17.1.71.
